No evidence of increased oxidative degradation of urate to allantoin in the CSF and serum of patients with multiple sclerosis

被引：0
|
作者：
S. Kastenbauer
B. C. Kieseier
B. F. Becker
机构：
[1] Ludwig–Maximilians–University,Dept. of Neurology
[2] Ludwig–Maximilians–University,Dept. of Physiology
[3] Heinrich–Heine–University,Dept. of Neurology
来源：
Journal of Neurology | 2005年 / 252卷
关键词：
Public Health; Multiple Sclerosis; Oxidative Degradation; Allantoin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：611 / 612
页数：1
相关论文
共 50 条
  • [21] Endothelin-1 serum levels are increased in patients with multiple sclerosis
    Criscuolo, C.
    Lanzillo, R.
    Cianflone, A.
    Postiglione, E.
    Liuzzi, R.
    Vacca, G.
    Caporale, O.
    Palladino, R.
    Triassi, M.
    Vastola, M.
    Moccia, M.
    Puorro, G.
    Marsili, A.
    Incoronato, M.
    Salvatore, M.
    Morra, V. Brescia
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 299 - 299
  • [22] Increased serum levels of some inflammatory markers in patients with multiple sclerosis
    Uysal, S.
    Yilmaz, F. Meric
    Bogdaycioglu, N.
    Ozturk, S. Mungan
    Ak, F.
    MINERVA MEDICA, 2014, 105 (03) : 229 - 235
  • [23] Increased serum levels of interleukin-18 in patients with multiple sclerosis
    Nicoletti, F
    Di Marco, R
    Mangano, K
    Patti, F
    Reggio, E
    Nicoletti, A
    Bendtzen, K
    Reggio, A
    NEUROLOGY, 2001, 57 (02) : 342 - 344
  • [24] Increased endothelin-1 serum levels in patients with multiple sclerosis
    Lanzillo, R.
    Criscuolo, C.
    Cianflone, A.
    Liuzzi, R.
    Postiglione, E.
    Moccia, M.
    Vastola, M.
    Puorro, G.
    Marsili, A.
    Incoronato, M.
    Mancini, M.
    Salvatore, M.
    Morra, V. Brescia
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 778 - 779
  • [25] Oxidative modification of serum proteins in multiple sclerosis
    Sadowska-Bartosz, Izabela
    Adamczyk-Sowa, Monika
    Galiniak, Sabina
    Mucha, Sebastian
    Pierzchala, Krystyna
    Bartosz, Grzegorz
    NEUROCHEMISTRY INTERNATIONAL, 2013, 63 (05) : 507 - 516
  • [26] CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis
    Mir, Fozia
    Lee, Donald
    Ray, Hetal
    Sadiq, Saud A.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2014, 1 (02):
  • [27] In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis
    Choi, In-Young
    Lee, Phil
    Adany, Peter
    Hughes, Abbey J.
    Belliston, Scott
    Denney, Douglas R.
    Lynch, Sharon G.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (08) : 1029 - 1038
  • [28] SOLUBLE CD8 LEVELS IN THE CSF AND SERUM OF PATIENTS WITH MULTIPLE-SCLEROSIS
    MAIMONE, D
    REDER, AT
    NEUROLOGY, 1991, 41 (06) : 851 - 854
  • [29] BAFF serum and CSF levels in patients with multiple sclerosis and infectious nervous system diseases
    Braun, Tobias
    Juenemann, Martin
    Dornes, Kathrin
    El-Shazly, Jasmin
    Schramm, Patrick
    Bick-Ackerschott, Sandra
    Kaps, Manfred
    Gerriets, Tibo
    Blaes, Franz
    Tschernatsch, Marlene
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2021, 131 (12) : 1231 - 1236
  • [30] Differential release of β-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis
    Sindern, E
    Niederkinkhaus, Y
    Henschel, M
    Ossege, LM
    Patzold, T
    Malin, JP
    ACTA NEUROLOGICA SCANDINAVICA, 2001, 104 (02): : 88 - 91
12345